My research interest is cancer research with a special focus on the design, synthesis, and radiopharmacological characterization of novel radiopharmaceuticals to optimize the current diagnosis and treatment of cancer. This research involves the use of PET radiopharmaceuticals and pre-clinical small animal PET imaging for non-invasive assessment of cancer-related metabolic pathways and biochemical processes at the cellular and molecular level. My current research activities include the design, synthesis, and characterization of novel molecular probes for targeting Autotaxin (ATX) and P2X7 receptors in cancer.

Research and collaboration in two M.Sc. student's projects on the synthesis of β-lactams

I worked on nitrogen aromatic heterocycles as Pim kinase inhibitors. The result of work was published in Bioorg. Med. Chem. with title Synthesis and activities of new indolopyrrolobenzodiazepine derivatives toward acute myeloid leukemia cells.